BACC
NASDAQ · N/A
Blue Acquisition Corp-Cl A
$10.52
+0.04 (+0.38%)
Open$10.49
Previous Close$10.48
Day High$10.53
Day Low$10.48
52W High$11.10
52W Low$9.99
Volume—
Avg Volume152.7K
Market Cap293.32M
P/E Ratio66.63
EPS$0.34
SectorN/A
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.44M | 9.19M | 8.42M |
| Net Income | 1.68M | 1.36M | 1.44M |
| Profit Margin | 17.8% | 14.8% | 17.1% |
| EBITDA | 1.98M | 2.08M | 2.05M |
| Free Cash Flow | 765.5K | 667.4K | 663.8K |
| Rev Growth | -5.7% | -2.9% | -3.8% |
| Debt/Equity | 0.62 | 0.61 | 0.65 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $2.07 | -3.94% | — | 1.28B |
| PICS | Pics Nv | $8.97 | +6.41% | 4.6 | 1.18B |
| DMII | Drugs Made In America Acquis | $10.19 | +0.00% | 49.9 | 649.10M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.19% | 42.2 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.27 | +0.00% | 41.3 | 586.93M |